AI Summary
✦ ClarthaValuation Metrics
Trading 17.7% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -0.93). Confidence: 78%.
Live forward EPS implies next-12-month EPS of ₹7.30. Applying the stock's normalized valuation corridor produces a fair range of ₹321.20 to ₹472.60, with base value near ₹378.80 (+126.7% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹7.30
Forward P/E
22.9x
Base Fair Value
₹378.80
Fair Range
₹321.20 - ₹472.60
Upside To Base
+126.7%
Estimate Source
Live forward EPS
Growth Estimate
+61.2%
5Y Average
54.67
Current
42.70
Overvalued
64.74
Undervalued
44.00
5Y Average
29.92
Current
23.15
Overvalued
33.72
Undervalued
24.67
5Y Average
1.59
Current
1.57
Overvalued
1.83
Undervalued
1.35
Peers & Comparison
Sector: Materials · Theme: Commodity Chemicals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
GUJARAT ALKALIES & CHEM GUJALKALICommodity Chemicals | +395.7% | 18.4% | 75.6x Premium | +52% vs avg | +20.5% |
INDIA GLYCOLS LTD INDIAGLYCOCommodity Chemicals | +13.1% | 7.0% | 23.6x Undervalued | -52% vs avg | +25.8% |
NOCIL LIMITED trades in line with peers (42.3x vs avg 49.6x), reflecting a fair valuation within the Commodity Chemicals cohort. Peers include GUJARAT ALKALIES & CHEM, INDIA GLYCOLS LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Free cash flow
₹81 CrMar 2026Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
Income statement data not available.
All values in ₹ Crores unless otherwise stated. Source: Company filings.